Eastman Chemical (NYSE: EMN) reported Q4 EPS of $1.39, $0.22 worse than the analyst estimate of $1.61. Revenue for the quarter came in at $2.38 billion versus the consensus estimate of $2.37 billion.

2019 Outlook

Commenting on the outlook for full-year 2019, Costa said: “We expect slower economic growth this year, with some of the challenges from the fourth quarter to persist in the first quarter. With this in mind, we remain focused on growing new business revenue leveraging our innovation-driven growth model. In addition, we expect to benefit from the flow through of lower raw material costs, aggressive cost management and returning cash to stockholders through continued significant share repurchases. We expect these actions will more than offset the negative impact of a strengthening U.S. dollar and projected higher pension costs. We therefore expect adjusted EPS growth in 2019 to be between 6 - 10 percent.”

The full-year 2019 projected earnings exclude any non-core, unusual or non-recurring items. Our 2019 financial results forecasts do not include non-core items (such as mark-to-market pension and other postretirement benefit gain or loss) or any unusual or non-recurring items, and we accordingly are unable to reconcile projected full-year 2019 earnings excluding non-core and any unusual or non-recurring items to reported GAAP earnings without unreasonable efforts.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.